Mightier Play and Caregiver Stress and Wellbeing
Launched by NEUROMOTION LABS · Dec 7, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Providing care for children with mental illness is associated with significant caregiver burden that manifests in physical, psychological, and social ways. Caregiver burden is largely associated with child symptom severity. As such, reducing child symptom severity should reduce caregiver burden. Yet, caregiver burden is not commonly assessed as an outcome of mental health interventions and little is known about the impact of child-focused novel digital mental health interventions on caregiver burden.
Mightier is an app-based biofeedback video game platform that utilizes heart rate (HR) mon...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent or caregivers have a child engaging with the heart rate biofeedback intervention Mightier
- • Parent or caregivers reside in the United States
- Exclusion Criteria:
- • None
About Neuromotion Labs
Neuromotion Labs is a pioneering clinical trial sponsor dedicated to advancing neurotechnology and therapeutic solutions for neurological disorders. By leveraging cutting-edge research and innovative methodologies, the company aims to enhance patient outcomes through rigorous clinical studies that explore the efficacy and safety of novel interventions. With a commitment to collaboration and scientific excellence, Neuromotion Labs strives to bridge the gap between research and real-world application, ultimately improving the quality of life for individuals affected by neurological conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials